Should prophylaxis for Pneumocystis jirovecii pneumonia be considered in patients with a CD4+ count higher than 200 cells/μl?

Orna Nitzan, Avi Peretz, Nina Pastukh, Margalit Lorber

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)2533-2534
Number of pages2
JournalAIDS
Volume29
Issue number18
DOIs
StatePublished - 28 Nov 2015

Cite this